Dissecting abdominal aortic aneurysm in angiotensin II-infused mice: The importance of imaging

Current Pharmaceutical Design

Volumn 21, Issue 28, 2015, Pages 4049-4060

  Trachet, Bram ^a,b   Fraga Silva, Rodrigo A ^b   Piersigilli, Alessandra ^b,c   Segers, Patrick ^a   Stergiopulos, Nikolaos ^b  

^a GHENT UNIVERSITY   (Belgium)

^b EPFL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Abdominal aortic aneurysms; Angiotensin II; Dissecting aneurysm; High frequency ultrasound; micro CT; Mouse model; MRI; PCXTM; Small animal imaging

Indexed keywords

ANGIOTENSIN II;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANATOMY; AORTA WALL; ARTERIAL STIFFNESS; BLOOD VESSEL RUPTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISSECTING ANEURYSM; DOPPLER FLOWMETRY; EX VIVO STUDY; HEMATOMA; HISTOPATHOLOGY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MORPHOLOGY; MOUSE MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOLOGY; PHASE CONTRAST X RAY COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; TUNICA MEDIA; ULTRASOUND; ANEURYSM, DISSECTING; ANEURYSM, RUPTURED; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODEL; HUMAN; MOUSE; PATHOPHYSIOLOGY; PROCEDURES;

ANEURYSM, DISSECTING; ANEURYSM, RUPTURED; ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; HEMATOMA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MICE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84947800932     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150826094746     Document Type: Review

References (102)

1. Alexander JJ. The pathobiology of aortic aneurysms. J Surg Res 2004; 117(1): 163-75.
2. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105(11): 1605-12.
3. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001; 134(4): 865-70.
4. Meng X, Yang J, Zhang K, et al. Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice. Hypertension 2014; 64(4): 875-82.
5. Mieth A, Revermann M, Babelova A, Weigert A, Schermuly RT, Brandes RP. l-type calcium channel inhibitor diltiazem prevents aneurysm formation by blood pressure-independent antiinflammatory effects. Hypertension 2013; 62(6): 1098-104.
6. Tan CK, Tan EH, Luo B, et al. SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS. J Am Heart Assoc Cardiovasc Cerebrovasc Dis 2013; 2(3): e000269.
7. Romain M, Taleb S, Dalloz M, et al. Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice-brief report. Arterioscler Thromb Vac Biol 2013; 33(3): 581-4.
8. Shen YH, Zhang L, Ren P, et al. AKT2 confers protection against aortic aneurysms and dissections. Circ Res 2013; 112(4): 618-32.
9. Zhang J, Chen H, Liu L, et al. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice 2012.
10. Revermann M, Mieth A, Popescu L, et al. A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm. Br J Pharmacol 2011; 163(8): 1721-32.
11. Schulte S, Sun J, Libby P, et al. Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. Am J Pathol 2010; 177(1): 456-63.
12. Chamberlain CM, Ang LS, Boivin WA, et al. Perforin-Independent Extracellular Granzyme B Activity Contributes to Abdominal Aortic Aneurysm. Am J Pathol 2010; 176(2): 1038-49.
13. Bai L, Beckers L, Wijnands E, et al. Cathepsin K gene disruption does not affect murine aneurysm formation. Atherosclerosis 2010; 209(1): 96-103.
14. Zhang Y, Naggar JC, Welzig CM, et al. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vac Biol 2009; 29(11): 1764-71.
15. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vac Biol 2009; 29(10): 1458-64.
16. Fraser H, Hislop C, Christie RM, et al. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. J Cardiovasc Pharmacol 2009; 53(1): 60-5.
17. Qian HS, Gu JM, Liu P, et al. Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice. Gene Ther 2007; 15(3): 224-32.
18. Gavazzi G, Deffert C, Trocme C, Schäppi M, Herrmann FR, Krause K-H. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 2007; 50(1): 189-96.
19. Martin-McNulty B, Tham DM, da Cunha V, et al. 17β-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vac Biol 2003; 23(9): 1627-32.
20. da Cunha V, Tham DM, Martin-McNulty B, et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005; 178(1): 9-17.
21. Cao RY, Adams MA, Habenicht AJ, Funk CD. Angiotensin IIinduced abdominal aortic aneurysm occurs independently of the 5- lipoxygenase pathway in apolipoprotein E-deficient mice. Prostaglandins Other Lipid Mediat 2007; 84(1-2): 34-42.
22. Ishibashi M, Egashira K, Zhao Q, et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 Is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vac Biol 2004; 24(11): e174-e8.
23. Satoh K, Nigro P, Matoba T, et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009; 15(6): 649-56.
24. Jones A, Deb R, Torsney E, et al. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms. Circulation 2009; 119(24): 3125-32.
25. Tedesco MM, Terashima M, Blankenberg FG, et al. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2009; 29(10): 1452.
26. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vac Biol 2003; 23(9): 1621-6.
27. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A. Prolonged infusion of angiotensin II in apoE-/- mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 2011; 179(3): 1542-8.
28. Jiang F, Jones GT, Dusting GJ. Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein (E)-deficient mice. Br J Pharmacol 2007; 152(6): 880-90.
29. Schriefl AJ, Collins MJ, Pierce DM, Holzapfel GA, Niklason LE, Humphrey JD. Remodeling of intramural thrombus and collagen in an Ang-II infusion ApoE-/- model of dissecting aortic aneurysms. Thromb Res 2012; 130(3): e139-e46.
30. Trachet B, Renard M, Van der Donckt C, et al. Longitudinal follow- up of ascending versus abdominal aortic aneurysm formation in angiotensin II-infused ApoE-/- mice. Artery Res 2014; 8(1): 16- 23.
31. Klink A, Heynens J, Herranz B, et al. In Vivo Characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol 2011; 58(24): 2522-30.
32. Wen J, Wang P, Smith SV, Haller CA, Chaikof EL. Syndecans are differentially expressed during the course of aortic aneurysm formation. J Vasc Surg 2007; 46(5): 1014-25.
33. Gavish L, Beeri R, Gilon D, et al. Arrest of progression of preinduced abdominal aortic aneurysm in apolipoprotein E-deficient mice by low level laser phototherapy. Lasers Surg Med 2014: n/an/ a.
34. Golledge J, Cullen B, Rush C, et al. Peroxisome proliferatoractivated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis 2010; 210(1): 51-6.
35. Gavish L, Rubinstein C, Bulut A, et al. Low-level laser irradiation inhibits abdominal aortic aneurysm progression in apolipoprotein E-deficient mice. Cardiovasc Res 2009; 83(4): 785-92.
36. Gavish L, Rubinstein C, Berlatzky Y, et al. Low level laser arrests abdominal aortic aneurysm by collagen matrix reinforcement in apolipoprotein E-deficient mice. Lasers Surg Med 2012; 44(8): 664-74.
37. Gavish L, Beeri R, Gilon D, et al. Inadequate reinforcement of transmedial disruptions at branch points subtends aortic aneurysm formation in apolipoprotein-E-deficient mice. Cardiovasc Pathol 2014; 23(3): 152-9.
38. Daugherty A, Cassis L. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y Acad Sci 1999; 892(1): 108-18.
39. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci 2002; 323(1): 3-10.
40. Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 2002; 7(1): 45-54.
41. Yamanouchi D, Morgan S, Kato K, Lengfeld J, Zhang F, Liu B. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein e-deficient mice. Arterioscler Thromb Vac Biol 2010; 30(4): 702-7.
42. Wang Y-X, Martin-McNulty B, da Cunha V, et al. Fasudil, a Rhokinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 2005; 111(17): 2219-26.
43. Maegdefessel L, Azuma J, Toh R, et al. Inhibition of microRNA- 29b reduces murine abdominal aortic aneurysm development. J Clin Investig 2012; 122(2): 497-506.
44. Qin Y, Cao X, Guo J, et al. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice 2012.
45. Tham DM, Martin-McNulty B, Wang Y-X, et al. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice 2002.
46. Daugherty A, Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 2004; 14(3): 117-20.
47. King VL, Trivedi DB, Gitlin JM, Loftin CD. Selective cyclooxygenase- 2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vac Biol 2006; 26(5): 1137-43.
48. Gitlin JM, Trivedi DB, Langenbach R, Loftin CD. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res 2007; 73(1): 227-36.
49. Zhang L-N, Velichko S, Vincelette J, et al. Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis 2008; 197(1): 204-11.
50. Turner GH, Olzinski AR, Bernard RE, et al. Assessment of macrophage infiltration in a Murine model of abdominal aortic aneurysm. J Magn Reson Imaging 2009; 30(2): 455-60.
51. Nahrendorf M, Keliher E, Marinelli B, et al. Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography- computed tomography. Arterioscler Thromb Vac Biol 2011; 31(4): 750-7.
52. Saito T, Hasegawa Y, Ishigaki Y, et al. Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation 2013.
53. Wang YX, Martin-McNulty B, Freay AD, et al. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein Edeficient mice. Am J Pathol 2001; 159(4): 1455-64.
54. Deng GG, Martin-McNulty B, Sukovich DA, et al. Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II- Induced Abdominal Aortic Aneurysm. Circ Res 2003; 92(5): 510-7.
55. Martin-McNulty B, Vincelette J, Vergona R, Sullivan ME, Wang Y-X. Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. Ultrasound Med Biol 2005; 31(6): 745-9.
56. Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, Daugherty A. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg 2006; 44(2): 372-6.
57. Deguchi J-O, Huang H, Libby P, et al. Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab Invest 2009; 89(3): 315-26.
58. Usui F, Shirasuna K, Kimura H, et al. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm. Arterioscler Thromb Vac Biol 2014 November 6, 2014.
59. Kitagawa T, Kosuge H, Chang E, et al. Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by 18Flabeled Arg-Gly-Asp positron-emission tomography. Circ Cardiovasc Imag 2013; 6(6): 950-6.
60. Turner GH, Olzinski AR, Bernard RE, et al. In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI. Circ Cardiovasc Imaging 2008; 1(3): 220-6.
61. Cao RY, Amand T, Ford MD, Piomelli U, Funk CD. The murine angiotensin II-induced abdominal aortic aneurysm model: rupture risk and inflammatory progression patterns. Front Pharmacol 2010 2010; 1: 9.
62. Yao Y, Wang Y, Zhang Y, et al. In vivo imaging of macrophages during the early-stages of abdominal aortic aneurysm using high resolution MRI in ApoE(-/-) Mice. PLoS One 2012; 7(3).
63. Xanthoulea S, Thelen M, Pöttgens C, Gijbels MJJ, Lutgens E, de Winther MPJ. Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS One 2009; 4(7): e6113.
64. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004; 24(3): 429-34.
65. Deguchi J-o, Huang H, Libby P, et al. Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab Invest 2009; 89(3): 315-26.
66. Zhang X, Thatcher S, Wu C, Daugherty A, Cassis LA. Castration of male mice prevents the progression of established angiotensin IIinduced abdominal aortic aneurysms. J Vasc Surg 2015; 61(3): 767- 76.
67. Xie X, Lu H, Moorleghen JJ, et al. Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice. PLoS One 2012; 7(9): e46411.
68. Nandlall SD, Goldklang MP, Kalashian A, Dangra NA, D'Armiento JM, Konofagou EE. Monitoring and staging abdominal aortic aneurysm disease with pulse wave imaging. Ultrasound Med Biol 2014; 40(10): 2404-14.
69. Zheng Y-H, Li F-D, Tian C, Ren H-L, Du J, Li H-H. Notch γ- secretase inhibitor dibenzazepine attenuates angiotensin II-induced abdominal aortic aneurysm in apoE knockout mice by multiple mechanisms. PLoS One 2013; 8(12): e83310.
70. Prins PA, Hill MF, Airey D, et al. Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure. PLoS One 2014; 9(1): e84517.
71. Sampson UK, Perati PR, Prins PA, et al. Quantitative estimates of the variability of in vivo sonographic measurements of the mouse aorta for studies of abdominal aortic aneurysms and related arterial diseases. J Ultrasound Med 2011; 30(6): 773-84.
72. Spin JM, Hsu M, Azuma J, et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Genomics 2011; 43(17): 993-1003.
73. Liu O, Jia L, Liu X, et al. Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II Induced- abdominal aortic aneurysm progression. PLoS One 2012; 7(12): e51707.
74. Subramanian V, Moorleghen JJ, Balakrishnan A, Howatt DA, Chishti AH, Uchida HA. Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain- 1 deficient mice. PLoS One 2013; 8(8): e72214.
75. Takahashi K, Matsumoto Y, Doe Z, et al. Combination therapy with atorvastatin and amlodipine suppresses angiotensin ii-induced aortic aneurysm formation. PLoS One 2013; 8(8): e72558.
76. Trachet B, Renard M, De Santis G, et al. An integrated framework to quantitatively link mouse-specific hemodynamics to aneurysm formation in angiotensin II-infused ApoE -/- mice. Ann Biomed Eng 2011; 39(9): 2430-44.
77. Wang Y, Ait-Oufella H, Herbin O, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 2010; 120(2): 422-32.
78. Hans CP, Koenig SN, Huang N, et al. Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation. Arterioscler Thromb Vasc Biol 2012; 32(12): 3012-23.
79. Favreau JT, Nguyen BT, Gao I, et al. Murine ultrasound imaging for circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model. J Vasc Surg 2012; 56(2): 462-9.
80. Golledge J, Cullen B, Moran C, Rush C. Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm. Cardiovasc Drugs Ther 2010 2010/12/01; 24(5-6): 373-8.
81. Moran CS, Jose RJ, Moxon JV, et al. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating CC chemokine receptor 2 positive monocytes. Arterioscler Thromb Vac Biol 2013; 33(4): 814-21.
82. Moran CS, Jose RJ, Biros E, Golledge J. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. Arterioscler Thromb Vac Biol 2014; 34(12): 2609-16.
83. Krishna SM, Seto SW, Moxon JV, et al. Fenofibrate increases highdensity lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 2012; 181(2): 706-18.
84. Luo J, Fujikura K, Tyrie LS, Tilson MD, III, Konofagou EE. Pulse wave imaging of normal and aneurysmal abdominal aortas in vivo. IEEE Trans Med Imaging 2009; 28(4): 477-86.
85. Wang Y-X, Martin-McNulty B, Freay AD, et al. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein Edeficient mice. Am J Pathol 2001; 159(4): 1455-64.
86. Ford MD, Black AT, Cao RY, Funk CD, Piomelli U. Hemodynamics of the mouse abdominal aortic aneurysm. J Biomech Eng 2011; 133(12).
87. Basu R, Fan D, Kandalam V, et al. Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin II. J Biol Chem 2012; 287(53): 44083-96.
88. Goergen CJ, Johnson BL, Greve JM, Taylor CA, Zarins CK. Increased anterior abdominal aortic wall motion: possible role in aneurysm pathogenesis and design of endovascular devices. J Endovascular Therapy 2007; 14(4): 574-84.
89. Paulus MJ, Sari-Saraff H, Gleason SS, et al. A new X-ray computed tomography system for laboratory mouse imaging. IEEE Trans Nucl Sci 1999(46): 558-64.
90. Badea CT, Hedlund LW, De Lin M, Boslego Mackel JF, Johnson GA. Tumor imaging in small animals with a combined micro- CT/micro-DSA system using iodinated conventional and blood pool contrast agents. Contrast Media Mol Imaging 2006; 1(4): 153-64.
91. Choke E, Cockerill GW, Dawson J, et al. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. J Vasc Surg 2010; 52(1): 159- 66.e1.
92. Goergen CJ, Azuma J, Barr KN, et al. Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler Thromb Vasc Biol 2011; 31(2): 270-U102.
93. Goergen CJ, Barr KN, Huynh DT, et al. In vivo quantification of murine aortic cyclic strain, motion, and curvature: implications for abdominal aortic aneurysm growth. J Magn Reson Imaging 2010; 32(4): 847-58.
94. Zampetaki A, Attia R, Mayr U, et al. Role of miR-195 in aortic aneurysmal disease. Circ Res 2014; 115(10): 857-66.
95. Fan LM, Douglas G, Bendall JK, et al. Endothelial cell-specific ROS production increases susceptibility to aortic dissection. Circulation 2014 May 7, 2014.
96. Amirbekian S, Long RC, Consolini MA, et al. In vivo assessment of blood flow patterns in abdominal aorta of mice with MRI: implications for AAA localization. Am J Physiol-Heart Circ Physiol 2009; 297(4): H1290-H5.
97. Stampanoni M, Borchert G, Wyss P, et al. High resolution X-ray detector for synchrotron-based microtomography. Nucl Instrum Meth A 2002; 491(1-2): 291-301.
98. McDonald SA, Marone F, Hintermuller C, et al. Advanced phasecontrast imaging using a grating interferometer. J Synchrotron Radiat 2009; 16(4): 562-72.
99. Trachet B, Fraga-Silva RA, Piersigilli A, et al. Dissecting abdominal aortic aneurysm in ang II-infused mice: suprarenal branch ruptures and apparent luminal dilatation. Cardiovasc Res 2015; 105(2): 213-22.
100. Tieu BC, Lee C, Sun H, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Investig 2009; 119(12): 3637-51.
101. Faugeroux J, Nematalla H, Li W, et al. Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice. Hypertension 2013; 62(1): 203-8.
102. Eagleton MJ, Xu J, Liao M, Parine B, Chisolm GM, Graham LM. Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation. J Vasc Surg 2010; 51(4): 951-61.